• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS EX filed by Tekla Healthcare Investors

    9/27/23 9:32:12 AM ET
    $HQH
    Finance Companies
    Finance
    Get the next $HQH alert in real time by email
    POS EX 1 tm2326781d1_posex.htm POS EX

     

    As filed with the Securities and Exchange Commission on September 27, 2023

     

    Securities Act File No. 333-195327

    Investment Company Act File No. 811-04889

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM N-2

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 x

    Pre-Effective Amendment No.

    Post-Effective Amendment No. 11

     

    REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 x

    Amendment No. 33

     

    TEKLA HEALTHCARE INVESTORS

    (Exact Name of Registrant as Specified in Charter)

     

    100 Federal Street, 19th Floor

    Boston, MA 02110
    (617) 772-8500

    (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s
    Principal Executive Offices)

     

    Daniel R. Omstead, Ph.D.
    100 Federal Street, 19th Floor

    Boston, MA 02110

    (Name, address including zip code, and telephone number, including area code, of agent for
    service)

     

    With Copies to:

     

    Christopher P. Harvey, Esq.
    Dechert LLP
    One International Place, 40th Floor

    100 Oliver Street
    Boston, MA 02110

     

    Approximate Date of Proposed Public Offering: As soon as practicable after the effective date of this Registration Statement

     

    If any securities being registered on this form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933, other than securities offered in connection with a dividend reinvestment plan, check the following box ¨.

     

    This post-effective amendment will become effective immediately pursuant to Rule 462(d).

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Post-Effective Amendment No. 11 to the Registration Statement on Form N-2 (File No. 333-195327) of Tekla Healthcare Investors (the “Registration Statement”) is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the “Securities Act”), solely for the purpose of filing an exhibit to the Registration Statement. No changes have been made to Part A, Part B or Part C of the Registration Statement, other than the Items of Part C of the Registration Statement as set forth below. Accordingly, this Post-Effective Amendment No. 11 consists only of a facing page, this explanatory note and Part C of the Registration Statement on Form N-2 setting forth the exhibits to the Registration Statement. This Post-Effective Amendment No. 11 does not modify any other part of the Registration Statement. The contents of the Registration Statement are hereby incorporated by reference.

     

    2

     

     

    PART C: OTHER INFORMATION

     

    Item 25. Financial Statements and Exhibits

     

    2.Exhibits:

     

    a.(i) Amended and Restated Declaration of Trust of the Registrant, dated as of April 21, 1987(4)

     

    (ii)Notice of Change of Trustee, dated June 2, 2003(5)

     

    (iii)Notice of Change of Trustee, dated September 20, 2006(1)

     

    (iv)Notice of Change of Trustee, dated July 2, 2007(1)

     

    (v)Notice of Change of Trustee, dated June 8, 2010(1)

     

    (vi)Notice of Change of Trustee, dated June 29, 2011(1)

     

    (vii)Amendment Relating to Repurchase of Shares, dated July 8, 2011(6)

     

    (viii)Notice of Change of Trustee, dated December 14, 2011(1)

     

    (ix)Notice of Change of Trustee, dated May 2, 2012(1)

     

    (x)Notice of Change of Trustee, dated December 20, 2017(7)

     

      (xi) Notice of Change of Trustee, dated December 13, 2018(8)

     

      (xii) Notice of Change of Trustee, dated June 20, 2019(9)

     

      (xiii) Notice of Change of Trustee, dated August 27, 2020(11)
         
      (xiv) Notice of Change of Trustee, dated June 16, 2021(12)
         
      (xv) Notice of Change of Trustee, dated December 13, 2021(13)
         
      (xvi) Notice of Change of Trustee, dated June 16th, 2022(14)
         
      (xvii) Notice of Change of Trustee, dated July 14, 2022(15)

     

    b.By-Laws of the Registrant, as amended, filed herewith

     

    c.Not Applicable

     

    d.(i) Specimen certificate for Shares of Beneficial Interest is incorporated by reference from Form N-2 Registration Statement (File No. 333-114322), filed May 26, 2004
       
      (ii) Form of Exercise Form(3)

     

    e.Dividend Reinvestment Plan of the Registrant dated May 1995 is incorporated by reference to Exhibit (e) to Registrant’s registration statement on Form N-2 (File No. 333-19247), filed January 3, 1997

     

    3

     

     

    f.Not Applicable

     

    g.Investment Advisory Agreement, dated as of July 1, 2009, between the Registrant and Tekla Capital Management LLC (formerly known as Hambrecht & Quist Capital Management, LLC) (1)

     

    h.Not Applicable

     

    i.Not Applicable

     

    j.Custodian Agreement, dated September 30, 2004, between the Registrant and State Street Bank and Trust Company(1)

     

    k.(i) Administration Agreement between Registrant and State Street Bank and Trust Company, dated as of July 1, 2005(1)

     

    (ii)Transfer Agency and Service Agreement between Registrant, Computershare Trust Company, N.A. and Computershare Shareholder Services, Inc. (formerly known as EquiServe, Inc.), dated as of March 1, 2006(1)

     

    (iii)Information Agent Agreement between the Registrant and AST Fund Solutions, LLC dated April 21, 2014(2)

     

    (iv)Subscription Agent Agreement between the Registrant and Boston Financial Data Services, Inc. dated April 30, 2014(2)

     

    (v)Support Services Agreement between the Registrant and Destra Capital Investments LLC dated January 1, 2016 (10)

     

    (vi)Assignment of the Support Services Agreement with Destra Capital Investments LLC to Destra Capital Advisors LLC dated April 2, 2018(7)

     

    l.Opinion and Consent of Dechert LLP(2)

     

    m.Not Applicable

     

    n.(i) Consent of Deloitte & Touche LLP, filed on May 28, 2014(3)

     

       (ii)Powers of Attorney dated March 28, 2014 and April 2, 2014(1); Power of Attorney dated April 9, 2018(7); Power of Attorney dated December 13, 2018(8); Power of Attorney dated August 27, 2020(11), Power of Attorney dated November 30, 2021(14), Power of Attorney dated June 9, 2022(15)

     

    o.Not Applicable

     

    p.Not Applicable

     

    q.Not Applicable

     

    4

     

     

    r.Code of Ethics of Registrant and its Investment Adviser(1)

     

     

    (1)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed April 16, 2014.

     

    (2)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed on May 23, 2014.

     

    (3)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed on May 28, 2014.

     

    (4)Incorporated by reference from Form N-2 Registration Statement (File No. 333-19247), filed January 3, 1997.

     

    (5)Incorporated by reference from Form N-2 Registration Statement (File No. 333-114322), filed April 8, 2004.

     

    (6)Incorporated by reference from Form N-2/A Registration Statement (File No. 811-04889), filed July 21, 2011.

     

    (7)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed April 18, 2018.

     

    (8)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed March 12, 2019.

     

    (9)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed June 20, 2019.
       
     (10)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed June 19, 2017.

     

     (11)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed September 10, 2020.
       
    (12)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed July 2, 2021.
       
     (13)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed December 22, 2021.
       
     (14) Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed July 1, 2022.
       
     (15)Incorporated by reference from Form N-2 Registration Statement (File No. 333-195327), filed July 29, 2022.

    5

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this Post-Effective Amendment No. 11 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston and Commonwealth of Massachusetts on the 27th day of September 2023.

     

      TEKLA HEALTHCARE INVESTORS
       
      By: /s/ Daniel R. Omstead
        President

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Name   Title   Date
             
    /s/ Daniel R. Omstead   Trustee and President (Principal Executive Officer)   September 27, 2023
    Daniel R. Omstead        
             
    /s/ Laura Woodward   Treasurer (Principal Financial Officer)   September 27, 2023
    Laura Woodward        
             
    /s/ Jeffrey A. Bailey ***   Trustee and Chairman of the Board   September 27, 2023
    Jeffrey A. Bailey        
             
    /s/ Kathleen L. Goetz****   Trustee   September 27, 2023
    Kathleen L. Goetz        
             
    /s/ Rakesh K. Jain*   Trustee   September 27, 2023
    Rakesh K. Jain        
             
    /s/ Thomas M. Kent**   Trustee   September 27, 2023
    Thomas M. Kent        
             
    /s/ W. Mark Watson*****   Trustee   September 27, 2023
    W. Mark Watson        

     

    *By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on April 16, 2014.

     

    **By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on April 18, 2018.

     

    *** By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on September 10, 2020.

     

    **** By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on December 22, 2021.

     

    *****By: Daniel R. Omstead as attorney-in-fact of each person so indicated and pursuant to the power of attorney previously filed on July 1, 2022.

     

    6

     

     

    EXHIBIT LIST

     

    (b)  By-Laws of the Registrant, as amended

     

    7

    Get the next $HQH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HQH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HQH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi

      8/9/24 4:17:00 PM ET
      $ACP
      $ASGI
      $AWP
      $FAX
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:HQH)(NYSE:HQL)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 28, 2024, on a per share basis to all shareholders of record as of June 21, 2024 (ex-dividend date June 21, 2024). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and abrdn Japan Equity Fund, Inc. (JEQ) which will pay on June 28, 2024, to al

      6/28/24 4:17:00 PM ET
      $ASGI
      $AWP
      $HQH
      $HQL
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Results of Annual Meeting of Shareholders

      PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:HQH)(NYSE:THQ)(NYSE:THW) announced they each held their Annual Meeting of Shareholders (the "Meetings") on June 25, 2024. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below:abrdn Healthcare Investors ("HQH")As of the record date, April 1, 2024, HQH had outstanding 50,624,847 shares of common stock. 80.52% of outstanding common stock were voted representing a quorum.Shareholders approved the election of two Class B Trustees to the Board: Number of Votes Cast ForPercentage of Votes Cast ForNumber of Votes Cast Against/WithheldPercentage of Votes Cast Against

      6/26/24 12:00:00 AM ET
      $ACP
      $HQH
      $THQ
      $THW
      Investment Managers
      Finance
      Finance Companies

    $HQH
    Leadership Updates

    Live Leadership Updates

    See more
    • abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

      PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has

      3/21/24 7:59:00 AM ET
      $AWP
      $HQH
      $HQL
      $THQ
      Trusts Except Educational Religious and Charitable
      Finance
      Finance Companies
      Investment Managers

    $HQH
    SEC Filings

    See more
    • SEC Form N-CEN filed by abrdn Healthcare Investors Shares of Beneficial Interest

      N-CEN - abrdn Healthcare Investors (0000805267) (Filer)

      12/16/24 11:48:21 AM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form N-CSR filed by abrdn Healthcare Investors Shares of Beneficial Interest

      N-CSR - abrdn Healthcare Investors (0000805267) (Filer)

      12/9/24 1:03:19 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form N-PX filed by abrdn Healthcare Investors Shares of Beneficial Interest

      N-PX - abrdn Healthcare Investors (0000805267) (Filer)

      8/30/24 6:11:25 PM ET
      $HQH
      Finance Companies
      Finance

    $HQH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Dimartino Rose bought $18,880 worth of shares (1,000 units at $18.88) (SEC Form 4)

      4 - abrdn Healthcare Investors (0000805267) (Issuer)

      7/18/24 2:54:48 PM ET
      $HQH
      Finance Companies
      Finance
    • Goetz Kathleen bought $8,622 worth of shares (525 units at $16.42), increasing direct ownership by 95% to 1,080 units (SEC Form 4)

      4 - abrdn Healthcare Investors (0000805267) (Issuer)

      4/12/24 9:19:10 AM ET
      $HQH
      Finance Companies
      Finance
    • Goodson Alan R bought $2,742 worth of shares (170 units at $16.13) (SEC Form 4)

      4 - abrdn Healthcare Investors (0000805267) (Issuer)

      1/9/24 12:09:55 PM ET
      $HQH
      Finance Companies
      Finance

    $HQH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      11/18/24 4:02:58 PM ET
      $HQH
      Finance Companies
      Finance
    • Amendment: SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      10/22/24 4:23:07 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form SC 13D/A filed by abrdn Healthcare Investors Shares of Beneficial Interest (Amendment)

      SC 13D/A - abrdn Healthcare Investors (0000805267) (Subject)

      5/3/24 7:15:52 AM ET
      $HQH
      Finance Companies
      Finance

    $HQH
    Financials

    Live finance-specific insights

    See more
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / August 9, 2024 / The following abrdn U.S. Closed-End Funds (NYSE:ACP)(NYSE:ASGI)(NYSE:AWP)(NYSE:HQH)(NYSE:HQL)(NYSE:IFN)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:FAX)(NYSE:FCO)(NYSE:IAF)(NYSE:VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 30, 2024 to all shareholders of record as of August 23, 2024 (ex-dividend date August 23, 2024). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equi

      8/9/24 4:17:00 PM ET
      $ACP
      $ASGI
      $AWP
      $FAX
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / PHILADELPHIA, PA / ACCESSWIRE / June 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE:HQH)(NYSE:HQL)(NYSE:JEQ)(NYSE:THQ)(NYSE:THW)(NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 28, 2024, on a per share basis to all shareholders of record as of June 21, 2024 (ex-dividend date June 21, 2024). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and abrdn Japan Equity Fund, Inc. (JEQ) which will pay on June 28, 2024, to al

      6/28/24 4:17:00 PM ET
      $ASGI
      $AWP
      $HQH
      $HQL
      Investment Managers
      Finance
      Trusts Except Educational Religious and Charitable
      Finance Companies
    • abrdn U.S. Closed-End Funds Announce Distribution Payment Details

      PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI, IFN, JEQ))) (NYSE:HQH, HQL, IAF, THQ, THW))), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 10, 2024, on a per share basis to all shareholders of record as of December 29, 2023 (ex-dividend date December 28, 2023). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), the India Fund, Inc. (IFN) and the abrdn Japan Equity Fund, Inc. (JEQ)

      1/10/24 4:17:00 PM ET
      $ACP
      $ASGI
      $HQH
      $HQL
      Investment Managers
      Finance
      Finance Companies
      Finance/Investors Services

    $HQH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Hepp Robert W.

      3 - abrdn Healthcare Investors (0000805267) (Issuer)

      3/20/25 4:36:06 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form 3 filed by new insider Gebauer Katie Lynn

      3 - abrdn Healthcare Investors (0000805267) (Issuer)

      3/20/25 4:32:38 PM ET
      $HQH
      Finance Companies
      Finance
    • SEC Form 3 filed by new insider Hasson Heather

      3 - abrdn Healthcare Investors (0000805267) (Issuer)

      3/20/25 4:28:38 PM ET
      $HQH
      Finance Companies
      Finance